Needs Assessment After Cancer in Patients Treated for Breast Cancer
NCT03902964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139
Last updated 2019-04-04
Summary
observational monocentric study
Conditions
- Breast Neoplasm Female
- Quality of Life
- Fear Cancer
Sponsors & Collaborators
-
Institut Jean-Godinot
lead OTHER
Principal Investigators
-
stephanie SERVAGI VERNAT, MD · Institut Jean-Godinot
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2019-02-01
- Completion
- 2019-02-01
Countries
- France
Study Locations
More Related Trials
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Breast Cancer and Quality of Life
NCT01661816 ·Status: COMPLETED
-
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641 ·Status: COMPLETED ·Phase: NA
-
A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
NCT01176838 ·Status: TERMINATED
-
Satisfaction Survey for the Outpatient Unit Dedicated to Post-cancer Treatment
NCT05530824 ·Status: COMPLETED
-
Impact of Body Mass Index on Outcomes of Breast Cancer Management
NCT03429504 ·Status: UNKNOWN
-
FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France
NCT03884413 ·Status: COMPLETED
-
Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT03859453 ·Status: COMPLETED
-
Breast CANcer Risk Assessment in Younger Women: BCAN-RAY
NCT05305963 ·Status: UNKNOWN
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Imaging Evaluation of the Therapeutic Response of Breast Cancer Bone Metastasis (EMOS)
NCT02900118 ·Status: COMPLETED
-
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
NCT05866458 ·Status: RECRUITING
-
Weight Variation During Chemotherapy in Breast Cancer Patients
NCT01506466 ·Status: COMPLETED ·Phase: NA
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
Breast Cancer and Chemo-amennorhea
NCT01867229 ·Status: COMPLETED
-
Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN)
NCT03255486 ·Status: COMPLETED ·Phase: NA
-
Economic and Social Disparities and Breast Cancer
NCT02948478 ·Status: COMPLETED
-
Predictive Clinical and Biological Parameters in Breast Cancer
NCT01521676 ·Status: TERMINATED ·Phase: NA
-
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
NCT02850302 ·Status: COMPLETED ·Phase: NA
-
Informed Decision Users of the Health System and Participation in Organized Screening for Breast Cancer
NCT02093039 ·Status: COMPLETED ·Phase: NA
-
Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
NCT06649565 ·Status: RECRUITING
-
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT05140252 ·Status: COMPLETED ·Phase: NA